# NKX2-5

## Overview
NKX2-5 is a gene that encodes the NK2 homeobox 5 protein, a transcription factor integral to cardiac development and function. This protein is characterized by a homeodomain, a helix-turn-helix structure that facilitates DNA binding and interaction with other transcription factors, playing a pivotal role in the regulation of gene expression during heart formation (Pradhan2012Crystal). NK2 homeobox 5 is involved in the differentiation and maturation of cardiomyocytes, influencing the expression of genes critical for electrical and mechanical functions of the heart (Anderson2018NKX25). The protein's interactions with other cardiac transcription factors, such as GATA4 and TBX5, underscore its importance in the combinatorial regulation of cardiac-specific genes (Pradhan2016Intermolecular; Lee1998The). Mutations in the NKX2-5 gene are linked to various congenital heart diseases, highlighting its clinical significance in maintaining cardiac structural and functional integrity (Benson1999Mutations).

## Structure
The NKX2-5 gene encodes a transcription factor that plays a crucial role in heart development. The protein contains a homeodomain, a 60-amino acid helix-turn-helix structure responsible for DNA binding (Pradhan2012Crystal). This homeodomain is centrally located within the protein and is essential for nuclear translocation and interaction with other transcription factors (Pradhan2012Crystal). The NKX2-5 homeodomain adopts a canonical fold with three α-helices and an N-terminal arm, with the α3 helix positioned in the major groove of the DNA (Pradhan2012Crystal). 

The protein's tertiary structure is stabilized by a hydrophobic core, which includes residues such as Phe8, Leu16, and Trp48, among others (Pradhan2012Crystal). The NKX2-5 protein can form homodimers, with the DNA containing two NK binding motifs in a palindromic arrangement (Pradhan2012Crystal). 

Post-translational modifications, such as phosphorylation, may occur, affecting the protein's function. NKX2-5 also has splice variants, which could influence its activity and interactions. The protein interacts with other cardiac transcription factors, such as TBX5, through less conserved surface residues, highlighting its role in combinatorial regulation of gene expression (Pradhan2014Crystallization).

## Function
The NKX2-5 gene encodes a transcription factor that plays a critical role in cardiac development and function. It is involved in regulating a transcriptional network essential for the differentiation and maturation of cardiomyocytes, the cells responsible for heart muscle contraction (Anderson2018NKX25). NKX2-5 is crucial for the formation of electrical and mechanical gene networks in cardiomyocytes, directly influencing the expression of ion channels and transporter genes, such as KCNH2b, and facilitating the incorporation of connexins like GJA1 into gap junctions, which are vital for electrical signal conduction (Anderson2018NKX25).

In healthy human cells, NKX2-5 represses smooth muscle gene expression to ensure the progression to a ventricular cardiac phenotype, while also regulating the genetic program of transient embryological structures, such as the second heart field and atrioventricular canal (Anderson2018NKX25). The gene is active in the nucleus, where it binds to DNA and interacts with other transcription factors, such as GATA4 and TBX20, to transactivate enhancer elements and regulate cardiac-specific gene expression (Anderson2018NKX25). This regulatory activity is crucial for maintaining the structural and functional integrity of the heart throughout development and into adulthood (Cao2023Nkx2.5:).

## Clinical Significance
Mutations in the NKX2-5 gene are associated with a range of congenital heart diseases (CHD), including atrial septal defect (ASD), ventricular septal defect (VSD), atrioventricular (AV) block, and tetralogy of Fallot (TOF) (Abou2015NKX25; Benson1999Mutations). These mutations often result in a loss of function, affecting the gene's ability to bind DNA and activate transcription, which is crucial for normal cardiac development (Kasahara2000Loss). Specific mutations, such as p.R190H and p.R190C, have been linked to AV block and ASD, with biochemical analyses showing reduced DNA-binding activity (Stallmeyer2010Mutational).

NKX2-5 mutations can also lead to arrhythmias and sudden cardiac death due to abnormalities in the cardiac conduction system, such as a disorganized Purkinje network and reduced cellular density in the AV node (Abou2015NKX25). In some cases, these mutations result in truncated proteins that may exert dominant-negative effects, further disrupting cardiac function (Kasahara2000Loss).

Alterations in NKX2-5 expression levels, particularly due to promoter variants, can enhance transcriptional activity, potentially contributing to conditions like VSD by upregulating gene expression (Pang2012Genetic). These genetic alterations underscore the clinical significance of NKX2-5 in cardiac pathologies.

## Interactions
NKX2-5, a crucial transcription factor in cardiac development, engages in several significant protein-protein and protein-DNA interactions. It interacts with the transcription factor GATA4, forming a complex that synergistically activates cardiac-specific promoters, such as the atrial natriuretic factor (ANF) gene. This interaction involves the homeodomain of NKX2-5 and the C-terminal zinc finger of GATA4, facilitating cooperative transcriptional activation (Lee1998The).

NKX2-5 also interacts with TBX5, another cardiac transcription factor. These interactions are essential for heart development, as they form homo- or hetero-multimeric complexes that bind to specific DNA motifs, regulating downstream target genes. The N-terminal domain of TBX5 plays a significant role in these interactions, and mutations in these genes are linked to congenital heart diseases (Pradhan2016Intermolecular).

Additionally, NKX2-5 interacts with MEF2, binding to overlapping DNA regions. This interaction involves a conserved protein-protein interface, which is crucial for cardiac differentiation and gene expression. Mutations in NKX2-5, such as R142C, can affect its interaction with MEF2 and other transcription factors, impacting DNA affinity and potentially leading to heart disease (Lei2020Crystal).


## References


[1. (Cao2023Nkx2.5:) Ce Cao, Lei Li, Qian Zhang, Haoran Li, Ziyan Wang, Aoao Wang, and Jianxun Liu. Nkx2.5: a crucial regulator of cardiac development, regeneration and diseases. Frontiers in Cardiovascular Medicine, December 2023. URL: http://dx.doi.org/10.3389/fcvm.2023.1270951, doi:10.3389/fcvm.2023.1270951. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcvm.2023.1270951)

[2. (Pradhan2012Crystal) Lagnajeet Pradhan, Caroli Genis, Peyton Scone, Ellen O. Weinberg, Hideko Kasahara, and Hyun-Joo Nam. Crystal structure of the human nkx2.5 homeodomain in complex with dna target. Biochemistry, 51(32):6312–6319, August 2012. URL: http://dx.doi.org/10.1021/bi300849c, doi:10.1021/bi300849c. This article has 39 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/bi300849c)

[3. (Lei2020Crystal) Xiao Lei, Jun Zhao, Jared M. Sagendorf, Niroop Rajashekar, Jiang Xu, Ana Carolina Dantas Machado, Chandani Sen, Remo Rohs, Pinghui Feng, and Lin Chen. Crystal structures of ternary complexes of mef2 and nkx2–5 bound to dna reveal a disease related protein–protein interaction interface. Journal of Molecular Biology, 432(19):5499–5508, September 2020. URL: http://dx.doi.org/10.1016/j.jmb.2020.07.004, doi:10.1016/j.jmb.2020.07.004. This article has 3 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.jmb.2020.07.004)

[4. (Pang2012Genetic) Shuchao Pang, Jiping Shan, Yanli Qiao, Liming Ma, Xianyun Qin, Hongxin Wanyan, Qining Xing, Guanghua Wu, and Bo Yan. Genetic and functional analysis of the nkx2-5 gene promoter in patients with ventricular septal defects. Pediatric Cardiology, 33(8):1355–1361, May 2012. URL: http://dx.doi.org/10.1007/s00246-012-0346-0, doi:10.1007/s00246-012-0346-0. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00246-012-0346-0)

[5. (Stallmeyer2010Mutational) B Stallmeyer, H Fenge, U Nowak‐Göttl, and E Schulze‐Bahr. Mutational spectrum in the cardiac transcription factor gene nkx2.5 (csx) associated with congenital heart disease. Clinical Genetics, 78(6):533–540, November 2010. URL: http://dx.doi.org/10.1111/j.1399-0004.2010.01422.x, doi:10.1111/j.1399-0004.2010.01422.x. This article has 81 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/j.1399-0004.2010.01422.x)

[6. (Benson1999Mutations) D. Woodrow Benson, G. Michael Silberbach, Ann Kavanaugh-McHugh, Carol Cottrill, Yizhong Zhang, Steve Riggs, Octavia Smalls, Mark C. Johnson, Michael S. Watson, J.G. Seidman, Christine E. Seidman, John Plowden, and John D. Kugler. Mutations in the cardiac transcription factor nkx2.5 affect diverse cardiac developmental pathways. Journal of Clinical Investigation, 104(11):1567–1573, December 1999. URL: http://dx.doi.org/10.1172/jci8154, doi:10.1172/jci8154. This article has 525 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci8154)

[7. (Lee1998The) Youngsook Lee, Tetsuo Shioi, Hideko Kasahara, Shawn M. Jobe, Russell J. Wiese, Bruce E. Markham, and Seigo Izumo. The cardiac tissue-restricted homeobox protein csx/nkx2.5 physically associates with the zinc finger protein gata4 and cooperatively activates atrial natriuretic factor gene expression. Molecular and Cellular Biology, 18(6):3120–3129, June 1998. URL: http://dx.doi.org/10.1128/MCB.18.6.3120, doi:10.1128/mcb.18.6.3120. This article has 341 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/MCB.18.6.3120)

[8. (Anderson2018NKX25) David J. Anderson, David I. Kaplan, Katrina M. Bell, Katerina Koutsis, John M. Haynes, Richard J. Mills, Dean G. Phelan, Elizabeth L. Qian, Ana Rita Leitoguinho, Deevina Arasaratnam, Tanya Labonne, Elizabeth S. Ng, Richard P. Davis, Simona Casini, Robert Passier, James E. Hudson, Enzo R. Porrello, Mauro W. Costa, Arash Rafii, Clare L. Curl, Lea M. Delbridge, Richard P. Harvey, Alicia Oshlack, Michael M. Cheung, Christine L. Mummery, Stephen Petrou, Andrew G. Elefanty, Edouard G. Stanley, and David A. Elliott. Nkx2-5 regulates human cardiomyogenesis via a hey2 dependent transcriptional network. Nature Communications, April 2018. URL: http://dx.doi.org/10.1038/s41467-018-03714-x, doi:10.1038/s41467-018-03714-x. This article has 80 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-018-03714-x)

[9. (Pradhan2016Intermolecular) Lagnajeet Pradhan, Sunil Gopal, Shichang Li, Shayan Ashur, Saai Suryanarayanan, Hideko Kasahara, and Hyun-Joo Nam. Intermolecular interactions of cardiac transcription factors nkx2.5 and tbx5. Biochemistry, 55(12):1702–1710, March 2016. URL: http://dx.doi.org/10.1021/acs.biochem.6b00171, doi:10.1021/acs.biochem.6b00171. This article has 38 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/acs.biochem.6b00171)

[10. (Pradhan2014Crystallization) Lagnajeet Pradhan, Sunil Gopal, and Hyun-Joo Nam. Crystallization and preliminary x-ray analysis of the cardiac transcription factor complex of nkx2.5 and tbx5 with dna. Acta Crystallographica Section F Structural Biology Communications, 70(5):592–595, April 2014. URL: http://dx.doi.org/10.1107/s2053230x14006761, doi:10.1107/s2053230x14006761. This article has 1 citations.](https://doi.org/10.1107/s2053230x14006761)

[11. (Abou2015NKX25) Ossama K. Abou Hassan, Akl C. Fahed, Manal Batrawi, Mariam Arabi, Marwan M. Refaat, Steven R. DePalma, J. G. Seidman, Christine E. Seidman, Fadi F. Bitar, and Georges M. Nemer. Nkx2-5 mutations in an inbred consanguineous population: genetic and phenotypic diversity. Scientific Reports, March 2015. URL: http://dx.doi.org/10.1038/srep08848, doi:10.1038/srep08848. This article has 37 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/srep08848)

[12. (Kasahara2000Loss) Hideko Kasahara, Bora Lee, Jean-Jacques Schott, D. Woodrow Benson, J.G. Seidman, Christine E. Seidman, and Seigo Izumo. Loss of function and inhibitory effects of human csx/nkx2.5 homeoprotein mutations associated with congenital heart disease. Journal of Clinical Investigation, 106(2):299–308, July 2000. URL: http://dx.doi.org/10.1172/jci9860, doi:10.1172/jci9860. This article has 124 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci9860)